464 related articles for article (PubMed ID: 37111579)
21. Nanocarriers Based Ocular Therapeutics: Updates, Challenges and Future Prospectives.
Kaushal U; Kaur M; Nagpal M; Bhuyan M; Gounder KP
Curr Drug Res Rev; 2023; 15(1):15-28. PubMed ID: 36100986
[TBL] [Abstract][Full Text] [Related]
22. Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases.
Onugwu AL; Nwagwu CS; Onugwu OS; Echezona AC; Agbo CP; Ihim SA; Emeh P; Nnamani PO; Attama AA; Khutoryanskiy VV
J Control Release; 2023 Feb; 354():465-488. PubMed ID: 36642250
[TBL] [Abstract][Full Text] [Related]
23. Intravitreal Injectable Hydrogels for Sustained Drug Delivery in Glaucoma Treatment and Therapy.
Akulo KA; Adali T; Moyo MTG; Bodamyali T
Polymers (Basel); 2022 Jun; 14(12):. PubMed ID: 35745935
[TBL] [Abstract][Full Text] [Related]
24. Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives.
Gaballa SA; Kompella UB; Elgarhy O; Alqahtani AM; Pierscionek B; Alany RG; Abdelkader H
Drug Deliv Transl Res; 2021 Jun; 11(3):866-893. PubMed ID: 32901367
[TBL] [Abstract][Full Text] [Related]
25. Targeted Nanotherapies for the Posterior Segment of the Eye: An Integrative Review on Recent Advancements and Challenges.
Gogoi NR; Marbaniang D; Pal P; Ray S; Mazumder B
Pharm Nanotechnol; 2022 Nov; 10(4):268-278. PubMed ID: 35946098
[TBL] [Abstract][Full Text] [Related]
26. Micelles: Promising Ocular Drug Carriers for Anterior and Posterior Segment Diseases.
Durgun ME; Güngör S; Özsoy Y
J Ocul Pharmacol Ther; 2020; 36(6):323-341. PubMed ID: 32310723
[TBL] [Abstract][Full Text] [Related]
27. An insight on ophthalmic drug delivery systems: Focus on polymeric biomaterials-based carriers.
Shafiq M; Rafique M; Cui Y; Pan L; Do CW; Ho EA
J Control Release; 2023 Oct; 362():446-467. PubMed ID: 37640109
[TBL] [Abstract][Full Text] [Related]
28. Challenges and strategies for ocular posterior diseases therapy via non-invasive advanced drug delivery.
Qi Q; Wei Y; Zhang X; Guan J; Mao S
J Control Release; 2023 Sep; 361():191-211. PubMed ID: 37532148
[TBL] [Abstract][Full Text] [Related]
29. Updates on Biodegradable Formulations for Ocular Drug Delivery.
Tsung TH; Chen YH; Lu DW
Pharmaceutics; 2023 Feb; 15(3):. PubMed ID: 36986595
[TBL] [Abstract][Full Text] [Related]
30. Overview of Recent Advances in Nano-Based Ocular Drug Delivery.
Liu LC; Chen YH; Lu DW
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895032
[TBL] [Abstract][Full Text] [Related]
31. Pharmaceutical, biomedical and ophthalmic applications of biodegradable polymers (BDPs): literature and patent review.
Osi B; Khoder M; Al-Kinani AA; Alany RG
Pharm Dev Technol; 2022 Mar; 27(3):341-356. PubMed ID: 35297285
[TBL] [Abstract][Full Text] [Related]
32. Ocular Drug Delivery Barriers-Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases.
Bachu RD; Chowdhury P; Al-Saedi ZHF; Karla PK; Boddu SHS
Pharmaceutics; 2018 Feb; 10(1):. PubMed ID: 29495528
[TBL] [Abstract][Full Text] [Related]
33. Applications of polymers in intraocular drug delivery systems.
Alhalafi AM
Oman J Ophthalmol; 2017; 10(1):3-8. PubMed ID: 28298856
[TBL] [Abstract][Full Text] [Related]
34. Advances in ocular drug delivery.
Rawas-Qalaji M; Williams CA
Curr Eye Res; 2012 May; 37(5):345-56. PubMed ID: 22510004
[TBL] [Abstract][Full Text] [Related]
35. Dually functional hollow ceria nanoparticle platform for intraocular drug delivery: A push beyond the limits of static and dynamic ocular barriers toward glaucoma therapy.
Luo LJ; Nguyen DD; Lai JY
Biomaterials; 2020 Jun; 243():119961. PubMed ID: 32171102
[TBL] [Abstract][Full Text] [Related]
36. Suprachoroidal Injection: A Novel Approach for Targeted Drug Delivery.
Wu KY; Fujioka JK; Gholamian T; Zaharia M; Tran SD
Pharmaceuticals (Basel); 2023 Sep; 16(9):. PubMed ID: 37765048
[TBL] [Abstract][Full Text] [Related]
37. Ocular drug delivery systems: An overview.
Patel A; Cholkar K; Agrahari V; Mitra AK
World J Pharmacol; 2013; 2(2):47-64. PubMed ID: 25590022
[TBL] [Abstract][Full Text] [Related]
38. Poly(ortho ester) nanoparticles targeted for chronic intraocular diseases: ocular safety and localization after intravitreal injection.
Li H; Palamoor M; Jablonski MM
Nanotoxicology; 2016 Oct; 10(8):1152-9. PubMed ID: 27108911
[TBL] [Abstract][Full Text] [Related]
39. Considerations for Polymers Used in Ocular Drug Delivery.
Allyn MM; Luo RH; Hellwarth EB; Swindle-Reilly KE
Front Med (Lausanne); 2021; 8():787644. PubMed ID: 35155469
[TBL] [Abstract][Full Text] [Related]
40. Nanomaterial-based ophthalmic drug delivery.
Xie G; Lin S; Wu F; Liu J
Adv Drug Deliv Rev; 2023 Sep; 200():115004. PubMed ID: 37433372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
